GenomeDx Biosciences Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:GenomeDx Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10449
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor aggressiveness to urologists and radiation oncologists. It also offers decipher genomics resource information database, a genomic expression database that helps for an open and interactive research collaboration and knowledge creation. GenomeDx serves patients with pregnancy, elderly care, chronic pain care regimens, Immunosuppressed conditions and diabetics. The company operates laboratories in San Diego. GenomeDx is headquartered in Vancouver, British Columbia, Canada.

GenomeDx Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GenomeDx Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GenomeDx Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
GenomeDx Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GenomeDx Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
GenomeDx Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GenomeDx Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
GenomeDx Raises USD3.4 Million in Venture Financing 10
GenomeDx Raises USD2.7 Million in Venture Financing 11
GenomeDx Biosciences Raises USD4.9 Million in Financing 12
GenomeDx Biosciences Secures USD25.39 Million in Venture Funding 13
GenomeDx Biosciences Raises Funds Through Series B Financing 14
GenomeDx Biosciences Secures Investment In Series A Financing 15
Partnerships 16
GenomeDx Biosciences Expands Research Collaboration With Mayo Clinic 16
GenomeDx Biosciences Enters into Co-Marketing Agreement with Pathnostics 17
GenomeDx Biosciences Enters into Agreement with Color Genomics 18
Bostwick Labs Enters into Agreement with GenomeDx Biosciences 19
GenomeDx Biosciences Enters into Distribution Agreement with SouthGenetics 20
GenomeDx Biosciences Enters into Agreement with Sidney Kimmel Cancer Center 21
GenomeDx Expands Research Agreement with Mayo Clinic 22
GenomeDx Biosciences Inc – Key Competitors 23
GenomeDx Biosciences Inc – Key Employees 24
GenomeDx Biosciences Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Corporate Communications 26
May 09, 2017: GenomeDx Appoints Michael Rodriguez as Chief Financial Officer 26
Product News 27
Feb 08, 2018: GenomeDx Biosciences’ Decipher Tests and Decipher GRID to be Featured in Multiple Presentations at 2018 Genitourinary Cancers Symposium 27
Jun 01, 2017: GenomeDx’s Decipher to be Featured in Multiple Presentations at ASCO 2017 30
May 11, 2017: GenomeDx’s Decipher GRID Aids in Development and Validation of Molecular Subtypes in Prostate Cancer that Predict Response to Hormone Therapy 31
Feb 14, 2017: GenomeDx’s Decipher Prostate, GRID and Bladder Data to be Featured in Multiple Presentations at the 2017 Genitourinary Cancers Symposium 32
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
GenomeDx Biosciences Inc, Medical Equipment, Key Facts 2
GenomeDx Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
GenomeDx Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GenomeDx Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
GenomeDx Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GenomeDx Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
GenomeDx Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GenomeDx Raises USD3.4 Million in Venture Financing 10
GenomeDx Raises USD2.7 Million in Venture Financing 11
GenomeDx Biosciences Raises USD4.9 Million in Financing 12
GenomeDx Biosciences Secures USD25.39 Million in Venture Funding 13
GenomeDx Biosciences Raises Funds Through Series B Financing 14
GenomeDx Biosciences Secures Investment In Series A Financing 15
GenomeDx Biosciences Expands Research Collaboration With Mayo Clinic 16
GenomeDx Biosciences Enters into Co-Marketing Agreement with Pathnostics 17
GenomeDx Biosciences Enters into Agreement with Color Genomics 18
Bostwick Labs Enters into Agreement with GenomeDx Biosciences 19
GenomeDx Biosciences Enters into Distribution Agreement with SouthGenetics 20
GenomeDx Biosciences Enters into Agreement with Sidney Kimmel Cancer Center 21
GenomeDx Expands Research Agreement with Mayo Clinic 22
GenomeDx Biosciences Inc, Key Competitors 23
GenomeDx Biosciences Inc, Key Employees 24
GenomeDx Biosciences Inc, Other Locations 25
GenomeDx Biosciences Inc, Subsidiaries 25

List of Figures
GenomeDx Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
GenomeDx Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
GenomeDx Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
GenomeDx Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
GenomeDx Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GenomeDx Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
GenomeDx Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GenomeDx Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[GenomeDx Biosciences Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Treet Corporation Ltd:企業の戦略・SWOT・財務情報
    Treet Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Treet Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Exagen Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Exagen Diagnostics Inc (Exagen) is a medical device company that offers diagnostic tools. The company provides clinical tools for diagnosis, monitoring and prognosis of autoimmune connective tissue disease. Its products are used for therapeutic drug monitoring of hydroxychloroquine in whole …
  • British Gas Ltd-エネルギー分野:企業M&A・提携分析
    Summary British Gas Limited (British Gas), a subsidiary of Centrica plc, is an energy utility company that undertakes the distribution of gas and electricity. It supplies electricity and gas to residential retail; commercial wholesale; and small, medium and large industrial customers. The company al …
  • Hydrogenics Corporation (HYG):企業の財務・戦略的SWOT分析
    Hydrogenics Corporation (HYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Mymetics Corp (MYMX):製薬・医療:M&Aディール及び事業提携情報
    Summary Mymetics Corp (Mymetics) is a biotechnology company that develops next-generation prophylactic vaccines for infectious diseases. The company's product pipeline includes vaccine candidates that target HIV-1/AIDS, chikungunya, intranasal influenza, malaria, herpes simplex virus (HSV) and respi …
  • Aiphone Co Ltd (6718):企業の財務・戦略的SWOT分析
    Aiphone Co Ltd (6718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • MAX Resource Corp. (MXR):企業の財務・戦略的SWOT分析
    MAX Resource Corp. (MXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • AMETEK Inc (AME):企業の財務・戦略的SWOT分析
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company's products portfolio include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titani …
  • Wentworth Resources Ltd (WRL):企業の財務・戦略的SWOT分析
    Wentworth Resources Ltd (WRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Teva Pharmaceuticals USA Inc:企業のM&A・事業提携・投資動向
    Teva Pharmaceuticals USA Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teva Pharmaceuticals USA Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Darling Ingredients Inc.:企業のM&A・事業提携・投資動向
    Darling Ingredients Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Darling Ingredients Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Huishang Bank Corp Ltd:企業の戦略・SWOT・財務分析
    Huishang Bank Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Huishang Bank Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Interfor Corp:企業の戦略・SWOT・財務情報
    Interfor Corp - Strategy, SWOT and Corporate Finance Report Summary Interfor Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Otter Tail Corp (OTTR):企業の財務・戦略的SWOT分析
    Otter Tail Corp (OTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Maxim Power Corp.:企業の発電所・SWOT分析2018
    Maxim Power Corp. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Cenovus Energy Inc (CVE):企業の財務・戦略的SWOT分析
    Cenovus Energy Inc (CVE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • KLA-Tencor Corporation:戦略・SWOT・企業財務分析
    KLA-Tencor Corporation - Strategy, SWOT and Corporate Finance Report Summary KLA-Tencor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Fubon Bank (Hong Kong) Limited:企業の戦略的SWOT分析
    Fubon Bank (Hong Kong) Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Genor BioPharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Genor BioPharma Co Ltd (Genor) a subsidiary of Walvax Biotechnology Co Ltd is a bio-pharmaceutical company which develops and commercializes therapeutic monoclonal antibodies (mAbs), Fc-fusion proteins and recombinant therapeutic proteins. Its service offerings include process and assay deve …
  • Innoviva Inc (INVA):企業の財務・戦略的SWOT分析
    Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆